Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma

作者: Abdel-Rahman N. Zekri , Abeer A. Bahnasy , Fatma elzahraa M. Shoeab , Waleed S. Mohamed , Dina H. El-Dahshan

DOI: 10.1016/J.JARE.2012.11.002

关键词:

摘要: We studied promoter methylation (PM) of 11 genes in Peripheral Blood Lymphocytes (PBLs) and tissues hepatitis C virus (HCV) associated hepatocellular carcinoma (HCC) chronic (CH) Egyptian patients. The present study included 31 HCC with their ANT, 38 CH 13 normal hepatic tissue (NHT) samples. In all groups, PM APC, FHIT, p15, p73, p14, p16, DAPK1, CDH1, RARβ, RASSF1A, O6MGMT was assessed by methylation-specific PCR (MSP). APC O6-MGMT protein expression immunohistochemistry (IHC) the (20 samples each) as well a different set for confirmation MSP results. progression from to HCC. Most showed high frequency (MF) index (MI) increased disease progression. MF CDH1 significantly higher ANT. CH. reported concordance between PBL O6MGMT. A panel 4 (APC, O6MGMT) classifies cases independently into accuracy (89.9%), sensitivity (83.9%) specificity (94.7%). HCV infection may contribute hepatocarcinogenesis through enhancing multiple genes. occurs early cascade while RARB, are late changes. could be used monitoring patients detection Also, we found that, status is not affected whether liver or PBL, indicating possibility use indicator genetic profile instead regardless stage disease.

参考文章(32)
Sheng Zhong, Winnie Yeo, Mandy W Tang, Nathalie Wong, Paul BS Lai, Phillip J Johnson, None, Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clinical Cancer Research. ,vol. 9, pp. 3376- 3382 ,(2003)
Eric C H Lai, Wan-Yee Lau, Hepatocellular carcinoma: current management and recent advances. Hepatobiliary & Pancreatic Diseases International. ,vol. 7, pp. 237- 257 ,(2008)
Gabriel Capella, Minoru Toyota, Manel Esteller, Stephen B. Baylin, Miguel Angel Peinado, James G. Herman, Silvia Tortola, Hypermethylation-associated Inactivation of p14ARF Is Independent of p16INK4a Methylation and p53 Mutational Status Cancer Research. ,vol. 60, pp. 129- 133 ,(2000)
Luke B. Hesson, Wendy N. Cooper, Farida Latif, The Role of RASSF1A Methylation in Cancer Disease Markers. ,vol. 23, pp. 73- 87 ,(2007) , 10.1155/2007/291538
S Matsukura, H Soejima, T Nakagawachi, H Yakushiji, A Ogawa, M Fukuhara, K Miyazaki, Y Nakabeppu, M Sekiguchi, T Mukai, CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. British Journal of Cancer. ,vol. 88, pp. 521- 529 ,(2003) , 10.1038/SJ.BJC.6600743
Monica Anzola, Nerea Cuevas, Monica L??pez-Mart??nez, Alberto Saiz, Juan Jos?? Burgos, Marian Mart??nez de Pancorbo, P14ARF gene alterations in human hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. ,vol. 16, pp. 19- 26 ,(2004) , 10.1097/00042737-200401000-00004
Kellie J. Archer, Valeria R. Mas, Daniel G. Maluf, Robert A. Fisher, High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma Molecular Genetics and Genomics. ,vol. 283, pp. 341- 349 ,(2010) , 10.1007/S00438-010-0522-Y
Kamal Ishak, Amelia Baptista, Leonardo Bianchi, Francesco Callea, Jan De Groote, Fred Gudat, Helmut Denk, Valeer Desmet, Gerhard Korb, Roderick N.M. MacSween, M.James Phillips, Bernard G. Portmann, Hemming Poulsen, Peter J. Scheuer, Martin Schmid, Heribert Thaler, Histological grading and staging of chronic hepatitis. Journal of Hepatology. ,vol. 22, pp. 696- 699 ,(1995) , 10.1016/0168-8278(95)80226-6
S Nomoto, T Kinoshita, K Kato, S Otani, H Kasuya, S Takeda, N Kanazumi, H Sugimoto, A Nakao, Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma British Journal of Cancer. ,vol. 97, pp. 1260- 1265 ,(2007) , 10.1038/SJ.BJC.6604016
Iris Tischoff, Annett Markwarth, Helmut Witzigmann, Dirk Uhlmann, Johann Hauss, Alireza Mirmohammadsadegh, Christian Wittekind, Ulrich R. Hengge, Andrea Tannapfel, Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. International Journal of Cancer. ,vol. 115, pp. 684- 689 ,(2005) , 10.1002/IJC.20944